OPIOID ALTERNATIVES ...
OPIOID ALTERNATIVES ...
AUTOMATE INTAKE
Lobbie: HIPAA-compliant intake, scheduling, charting platform with HL7/FHIR/API integrations and direct link to EHRs like Athenahealth, AdvancedMD, DrChrono. Lobbie+1
IntakeQ (PracticeQ): Digital intake forms that auto-upload to EHRs (e.g., Elation, RevolutionEHR) and sync demographics/insurance. IntakeQ Support+1
Zentake: HIPAA-compliant online form builder tailored to clinics; downloadable entries (CSV/PDF) and basic EHR integration support. Zentake+1
Formstack (Healthcare): No-code forms + API; integrates with EHRs, Salesforce Health Cloud, and supports open API for full EHR/PM connectivity. Formstack+1
PracticeQ: (Part of IntakeQ) Enables EHR uploads, insurance sync, API access, and connectors to multiple clinical/PM systems. IntakeQ Support
CERVICAL
LUMBAR +
THORACIC / SCOLIOSIS
KNEE
WRIST
TPI
TPI
ONB
KNEE
SHOULDER
(WRIST, ELBOW / BURSA, TROCHANTERIC BURSA /
(Awareness: Lung Cancer, Diabetes, COPD)
How common is lung cancer?
Lung cancer is the leading cause of cancer death worldwide. About 1 in 16 men and 1 in 17 women will be diagnosed in their lifetime. While smoking remains the biggest driver, 10–20% of cases occur in never-smokers, often linked to radon or genetic changes.
How does screening reduce deaths?
Low-dose CT (LDCT) screening in high-risk groups lowers mortality by catching cancers at stage I instead of stage IV. The NLST trial showed a ~20% reduction in lung cancer deaths. Screening exemplifies how imaging, when applied systematically, changes survival curves.
What are current therapies?
Treatment ranges from surgery and radiation to immunotherapy and targeted drugs. EGFR, ALK, and KRAS mutations are now matched with precision therapies. This is a shift from “one-size-fits-all” chemotherapy toward molecular oncology.
What is the prognosis today?
Five-year survival is ~25% overall but >60% when localized. Prognosis improves with early detection, making adherence to screening guidelines essential. Survival statistics reflect the success of both prevention and biomedical innovation.
How common is diabetes?
Over 37 million Americans have diabetes, and 1 in 5 don’t know they have it. It contributes to cardiovascular disease, renal failure, and neuropathy. Its rising prevalence parallels obesity and sedentary lifestyles.
What are the types?
Type 1 = autoimmune destruction of beta cells. Type 2 = insulin resistance with relative deficiency. Gestational diabetes occurs in pregnancy and raises future risk for both mother and child.
What are modern treatments?
Beyond insulin, therapies include metformin, SGLT2 inhibitors, and GLP-1 receptor agonists. These not only lower glucose but reduce cardiovascular and kidney events. GLP-1 agonists also aid weight loss, tackling obesity and diabetes together.
How does prevention work?
Lifestyle intervention (diet + exercise) can cut type 2 diabetes incidence by 58% in high-risk individuals. Preventive care blends public health (nutrition policy, activity programs) with clinical risk factor screening.
How common is COPD?
COPD affects ~16 million diagnosed Americans, with many more undiagnosed. It is the third leading cause of death worldwide. Tobacco is the main risk, but biomass fuel and occupational exposures also matter globally.
How is COPD diagnosed?
Spirometry confirms airflow limitation (FEV1/FVC <0.7). Symptoms include cough, sputum, and dyspnea. Early diagnosis allows smoking cessation and therapy before irreversible lung damage.
What are modern treatments?
Bronchodilators (LAMA, LABA), inhaled steroids, and pulmonary rehab form the backbone. Long-term oxygen improves survival in hypoxemic patients. New biologics for eosinophilic inflammation are under study.
What is the prognosis?
COPD is progressive but modifiable. Smoking cessation slows decline. Prognosis is guided by GOLD staging, exacerbation frequency, and comorbidities. Multimodal management extends life and function.
References (November):
CDC Lung Cancer Screening: https://www.cdc.gov/cancer/lung/basic_info/screening.htm
NLST Trial – NEJM 2011: https://pubmed.ncbi.nlm.nih.gov/21714641/
CDC Diabetes Facts: https://www.cdc.gov/diabetes/library/features/diabetes-stat-report.html
Diabetes Prevention Program: https://pubmed.ncbi.nlm.nih.gov/11832527/
GOLD COPD Guidelines: https://goldcopd.org
(Awareness: Lung Cancer, Diabetes, COPD)
How common is lung cancer?
Lung cancer is the leading cause of cancer death worldwide. About 1 in 16 men and 1 in 17 women will be diagnosed in their lifetime. While smoking remains the biggest driver, 10–20% of cases occur in never-smokers, often linked to radon or genetic changes.
How does screening reduce deaths?
Low-dose CT (LDCT) screening in high-risk groups lowers mortality by catching cancers at stage I instead of stage IV. The NLST trial showed a ~20% reduction in lung cancer deaths. Screening exemplifies how imaging, when applied systematically, changes survival curves.
What are current therapies?
Treatment ranges from surgery and radiation to immunotherapy and targeted drugs. EGFR, ALK, and KRAS mutations are now matched with precision therapies. This is a shift from “one-size-fits-all” chemotherapy toward molecular oncology.
What is the prognosis today?
Five-year survival is ~25% overall but >60% when localized. Prognosis improves with early detection, making adherence to screening guidelines essential. Survival statistics reflect the success of both prevention and biomedical innovation.
How common is diabetes?
Over 37 million Americans have diabetes, and 1 in 5 don’t know they have it. It contributes to cardiovascular disease, renal failure, and neuropathy. Its rising prevalence parallels obesity and sedentary lifestyles.
What are the types?
Type 1 = autoimmune destruction of beta cells. Type 2 = insulin resistance with relative deficiency. Gestational diabetes occurs in pregnancy and raises future risk for both mother and child.
What are modern treatments?
Beyond insulin, therapies include metformin, SGLT2 inhibitors, and GLP-1 receptor agonists. These not only lower glucose but reduce cardiovascular and kidney events. GLP-1 agonists also aid weight loss, tackling obesity and diabetes together.
How does prevention work?
Lifestyle intervention (diet + exercise) can cut type 2 diabetes incidence by 58% in high-risk individuals. Preventive care blends public health (nutrition policy, activity programs) with clinical risk factor screening.
How common is COPD?
COPD affects ~16 million diagnosed Americans, with many more undiagnosed. It is the third leading cause of death worldwide. Tobacco is the main risk, but biomass fuel and occupational exposures also matter globally.
How is COPD diagnosed?
Spirometry confirms airflow limitation (FEV1/FVC <0.7). Symptoms include cough, sputum, and dyspnea. Early diagnosis allows smoking cessation and therapy before irreversible lung damage.
What are modern treatments?
Bronchodilators (LAMA, LABA), inhaled steroids, and pulmonary rehab form the backbone. Long-term oxygen improves survival in hypoxemic patients. New biologics for eosinophilic inflammation are under study.
What is the prognosis?
COPD is progressive but modifiable. Smoking cessation slows decline. Prognosis is guided by GOLD staging, exacerbation frequency, and comorbidities. Multimodal management extends life and function.
References (November):
CDC Lung Cancer Screening: https://www.cdc.gov/cancer/lung/basic_info/screening.htm
NLST Trial – NEJM 2011: https://pubmed.ncbi.nlm.nih.gov/21714641/
CDC Diabetes Facts: https://www.cdc.gov/diabetes/library/features/diabetes-stat-report.html
Diabetes Prevention Program: https://pubmed.ncbi.nlm.nih.gov/11832527/
GOLD COPD Guidelines: https://goldcopd.org
(Awareness: HIV/AIDS, Influenza, RSV)
How common is HIV?
Over 1.2 million people in the U.S. live with HIV. About 13% are unaware, fueling continued transmission. Globally, 39 million live with HIV.
How is HIV prevented today?
Condom use, harm reduction, and now PrEP (pre-exposure prophylaxis) significantly reduce new infections. “U=U” (undetectable = untransmittable) shows effective therapy prevents sexual transmission entirely.
What are treatments?
Combination antiretroviral therapy suppresses viral load to undetectable levels. Life expectancy now approaches that of the general population when adherence is consistent. HIV has transformed from fatal to chronic with proper management.
What is the prognosis with care?
Patients on therapy can expect decades of healthy life. Mortality is more often due to comorbid conditions like cardiovascular disease than HIV itself. Adherence and early diagnosis are key determinants.
How common is flu?
Flu causes 9–41 million illnesses and up to 52,000 deaths annually in the U.S. Severity varies by season, age, and strain. It remains a top cause of preventable morbidity.
How does vaccination help?
Flu shots reduce hospitalization by 40–60% even in years with partial strain mismatch. Herd vaccination protects infants, elderly, and immunocompromised. It’s the best population tool against seasonal surges.
What are treatments?
Antivirals like oseltamivir shorten illness if given early. Severe cases may require hospitalization and supportive care. High-risk groups should receive prompt testing and treatment.
How to prevent flu spread?
Vaccination, hand hygiene, masking, and staying home when ill. Non-pharmaceutical interventions gained renewed emphasis after COVID-19, showing their role in respiratory infection control.
What is RSV?
RSV is a leading cause of lower respiratory tract infections in infants and hospitalizations in older adults. Most children are infected by age 2.
How serious is RSV in adults?
In older adults, RSV causes ~60,000 hospitalizations annually in the U.S. Immunosenescence and chronic lung/cardiac conditions worsen outcomes.
What are new preventive tools?
2023 brought the first adult RSV vaccines (Arexvy, Abrysvo) and maternal vaccination for infant protection. Monoclonal antibodies (nirsevimab) protect infants directly.
What is the outlook?
With vaccines, RSV burden may decline significantly. Public health integration into flu/COVID programs will determine real-world impact. Prevention will likely mirror influenza strategies in coming years.
References (December):
HIV.gov World AIDS Day: https://www.hiv.gov/events/awareness-days/world-aids-day
CDC HIV Basics: https://www.cdc.gov/hiv/basics/index.html
CDC Influenza: https://www.cdc.gov/flu/index.htm
CDC RSV: https://www.cdc.gov/rsv/index.html
FDA RSV Vaccine Approvals: https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine